Literature DB >> 2391251

HLA-DP beta and susceptibility to multiple sclerosis: an analysis of caucasoid and Japanese patient populations.

A B Begovich1, R C Helmuth, J R Oksenberg, K Sakai, T Tabira, T Sasazuki, L Steinman, H A Erlich.   

Abstract

Nonradioactive sequence-specific oligonucleotide (SSO) probes specific for the HLA-DP beta locus have been used in a simple dot-blot assay to DP beta-type samples amplified by the polymerase chain reaction (pcr) from Caucasoid (n = 24) and Japanese (n = 23) patients with multiple sclerosis (ms) as well as ethnically matched controls. In contrast to previous reports, no DP beta allele was found to be increased in either patient population. However, the results do show a dramatic difference in the allele frequencies between the two control populations, further emphasizing the need for ethnically matched controls in studies of HLA and disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391251     DOI: 10.1016/0198-8859(90)90031-j

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Immunogenetics of multiple sclerosis and optic neuritis: DNA polymorphism of HLA class II genes.

Authors:  N Morling; M Sandberg-Wollheim; L Fugger; J Georgsen; J J Hylding-Nielsen; H O Madsen; K Rieneck; L Ryder; A Svejgaard
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  PCR/oligonucleotide probe typing of HLA class II alleles in a Filipino population reveals an unusual distribution of HLA haplotypes.

Authors:  T L Bugawan; J D Chang; W Klitz; H A Erlich
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

3.  Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes.

Authors:  T L Bugawan; A B Begovich; H A Erlich
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer.

Authors:  Jill A Hollenbach; Abeer Madbouly; Loren Gragert; Cynthia Vierra-Green; Susan Flesch; Stephen Spellman; Ann Begovich; Harriet Noreen; Elizabeth Trachtenberg; Tom Williams; Neng Yu; Bronwen Shaw; Katharina Fleischhauer; Marcelo Fernandez-Vina; Martin Maiers
Journal:  Immunogenetics       Date:  2012-04-13       Impact factor: 2.846

5.  No direct correlation between HLA-DPB1 and antibodies against recombinant Ro (SS-A)/La (SS-B) proteins in systemic lupus erythematosus. SLE Study Group.

Authors:  Z Yao; K Hartung; H Ehrfeld; H P Seelig; H G Deicher; G Brünnler; E Keller; E Albert
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

6.  HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk.

Authors:  Kevin Y Urayama; Anand P Chokkalingam; Catherine Metayer; Xiaomei Ma; Steve Selvin; Lisa F Barcellos; Joseph L Wiemels; John K Wiencke; Malcolm Taylor; Paul Brennan; Gary V Dahl; Priscilla Moonsamy; Henry A Erlich; Elizabeth Trachtenberg; Patricia A Buffler
Journal:  Blood       Date:  2012-08-24       Impact factor: 22.113

Review 7.  Polyomavirus models of brain infection and the pathogenesis of multiple sclerosis.

Authors:  G L Stoner
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.